Citigroup

Victoria's Secret and Bath & Body Works parent company L Brands Inc (NYSE: LB) was upgraded by Citi on Monday, with an analyst saying the market's valuation of the retailer is overly bearish.  The Analyst Citi's Paul Lejuez upgraded L Brands from Neutral to Buy and...

Alcoa Corp (NYSE: AA) shares have returned 60 percent over the past year, rendering their valuation unattractive, according to an analyst at Citigroup. On Monday, however, the stock plummeted 13 percent after the U.S. Treasury issued a six-month reprieve on sanctions levied on Rusal, one of Alcoa...

This weekend's Barron's cover story shows how trade tensions will test companies and investors. Other featured articles question whether earnings can save the bull market and present the results of the latest Big Money Poll. Also, the prospects for a powerhouse regional bank and a...

This weekend's Barron's cover story shows how Canadian pot stocks are preparing for marijuana legalization. Other featured articles examine the risks posed by big tech stocks and why oil refiners have a profitable future. Also, the prospects for semiconductor makers and a bank...

Tesla Inc (NASDAQ: TSLA) will soon release its first-quarter production numbers, and analyst expectations span the bull-to-bear spectrum. Here is one less-than-optimistic perspective. The Rating Citigroup analyst Itay Michaeli maintained a Neutral/High Risk rating on the stock without a price...

CF Industries Holdings, Inc. (NYSE: CF) shares have jumped 42 percent over the past year, prompting a downgrade by Citi on valuation. The Analyst Citi analyst P.J. Juvekar downgrades shares of CF Industries from Buy to Neutral and lowered the price target from $47 to $45. The Thesis CF...

Rayonier Inc. (NYSE: RYN) is a timberland REIT with assets in the U.S. and New Zealand. The company recently announced the addition of a Marcato Capital Management executive to its board. The Analyst Citigroup analyst Anthony Pettinari initiated coverage of the shares of Rayonier with a Neutral...

Pre-open movers U.S. stock futures traded lower in early pre-market trade. Data on durable goods orders for January, international trade in goods for January and wholesale inventories for January will be released at 8:30 a.m. ET. The S&P Corelogic Case-Shiller home price index for December and...

Despite shares of ADT Inc (NYSE: ADT) trading at a discount to the offer price of $14, sell-side analysts are optimistic about the security company's prospects. Most sell-side firms, including Goldman Sachs, Morgan Stanley and Imperial Capital, initiated coverage of ADT with the highest...

Gilead Sciences, Inc. (NASDAQ: GILD) is a biopharma company focused on treatments for HIV/AIDS, liver disease, cancer, inflammatory and respiratory, and cardiovascular conditions. The Analyst Citigroup analyst Robyn Karnauskas upgraded shares of Gilead Sciences from Neutral to Buy, with a $...

Esperion Therapeutics Inc (NASDAQ: ESPR) is finishing research on its bemepedoic acid for lipid management, and while the Street expects success, the drug’s potential is weighted by a dearth of interested buyers. The Rating Citi analyst Joel Beatty downgraded Esperion to Neutral, but raised...

Identity management software provider Sailpoint Technologies Holdings Inc (NYSE: SAIL)'s IPO quiet period expired Tuesday, and the sell side initiated coverage of the stock. Operating in Attractive Markets Jefferies analyst John DiFucci said SailPoint operates in the attractive identity...

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) announced Monday the failure and discontinuation of two trials for angiopoietin2. Between this and rising rivals, Regeneron bears are emerging. The Rating Citigroup analyst Robyn Karnauskas downgraded Regeneron from Buy to Neutral and lowered the price...

PACCAR Inc (NASDAQ: PCAR) may be left with few stock catalysts. With the upside potential limited by the timing of the trucking cycle, Citigroup said in a Wednesday note that it's moving to the sidelines. The Analyst Citigroup analyst Timothy Thein downgraded shares of PACCAR from Buy...